ClosedLoop.ai, healthcare’s data science platform, announced a $34 million Series B round. ClosedLoop’s AI-based solutions predict and explain a wide range of outcomes and avoidable adverse events and are increasingly used when making decisions about patient care.

The Series B was led by Telstra Ventures with participation from Breyer Capital, Greycroft Ventures, .406 Ventures, and Healthfirst, positions ClosedLoop to extend its lead in delivering artificial intelligence (AI) solutions that tackle some of healthcare’s biggest challenges. Notable angel investors Adam Boehler (former director of CMMI & CEO of Rubicon Founders) and Sam Palmisano (former CEO of IBM) also participated in the round.

Raised: $34.0M

Round: Series B

Funding Date: August 2021

Lead Investor: Telstra Ventures

Additional Investors: Breyer Capital, Greycroft Ventures, .406 Ventures, and Healthfirst

Company Website: https://www.closedloop.ai/

Software Category: Healthcare Software > Artificial Intelligence

About the Company: ClosedLoop.ai is healthcare’s data science platform. They make it easy for healthcare organizations to use AI to improve outcomes and reduce costs. ClosedLoop combines an intuitive end-to-end machine learning platform with a comprehensive library of healthcare-specific features and model templates. Customers use ClosedLoop’s Explainable AI to drive clinical excellence, operational efficiency, value-based contracts, and enhanced revenue. ClosedLoop is headquartered in Austin, Texas.

Source: https://www.closedloop.ai/news/closedloop-ai-raises-34m-series-b-to-usher-in-ai-enabled-healthcare-and-tackle-trillion-dollar-healthcare-problem